Skip to content

A Randomised Controlled Trial of Cyanoacrylate Glue Versus Vicryl for skin closure at Caesarean Section at Federal Teaching Hospital, Katsina

A Randomised Controlled Trial of Cyanoacrylate Glue Versus Vicryl for skin closure at Caesarean Section at Federal Teaching Hospital, Katsina

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202407496762405
Enrollment
70
Registered
2024-07-26
Start date
2024-04-02
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin closure at Caesarean Section

Interventions

Use of N butyl cyanoacrylate glue for skin closure at Caesarean Section
Subcuticular Vicryl

Sponsors

Adamu Saminu Adamu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients of FMCK undergoing Caesarean section with Pfannenstiel or Joel Cohen skin incision between the ages of 18 and 45 years, from 28 weeks 0 days to 41 weeks 6 days of gestation.

Exclusion criteria

Exclusion criteria: Patients with the following will be excluded: 1. Previous hypersensitivity to N-butyl cyanoacrylate glue 2. Asthmatic patients 3. Extremes of maternal weight; 90kg 4. Diabetes mellitus 5. Anaemia; PCV 24hrs 9. Patients with Intra uterine fetal death (IUFD) 10. Obstructed labour 11. Keloid scarring 12. Immunosuppressive disease conditions e.g., HIV, Systemic Lupus Erythematosus (SLE), Anti phospholipid syndrome, multiple sclerosis 13. Immunosuppressive treatment e.g., prolonged use of systemic steroids >3 months 14. Primary or previous Caesarean section not using Pfannenstiel or Joel Cohen incision 15. Do not consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
Primary outcome measure To compare the scar outcome on day 5 (SCAR1) and at 6 weeks (SCAR2) post-operatively using SCAR scale in both the study and control group.

Secondary

MeasureTime frame
Secondary outcome measures 1. To compare the time taken for skin closure in both the study and control group. 2. To compare self-assessed pain 6 hours post-operatively using NPRS in both the study and control group. 3. To compare wound complications (wound dehiscence and superficial surgical site infection) at day 5 and at 6 weeks post operation in both the study and control group. 4. To assess and compare the patient’s and surgeons’ satisfaction using Scar VSS in both the study and control group.

Countries

Nigeria

Contacts

Public ContactYusuf Shuaibu

Consultant Gynaecologist

adamsadam2000@yahoo.com+2348035923946

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026